VIELA BIO, INC. Operating Cash Flow
VIELA BIO, INC. reported Operating Cash Flow of -$106.11 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-03-01
- VIELA BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$8.46M.
- VIELA BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2020-09-30 was -$40.09M.
- VIELA BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2020-06-30 was -$46.69M.
- VIELA BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$10.87M.
- VIELA BIO, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$106.11M.
- VIELA BIO, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$105.05M.
- VIELA BIO, INC. net cash provided by (used in) operating activities for fiscal 2018 was -$29.53M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$8.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$48.55M derived: sum of 2 quarters · filed 2021-03-01 | -$95.24M derived: sum of 3 quarters · filed 2021-03-01 | -$106.11M 10-K · filed 2021-03-01 |
| 2020-09-30 | -$40.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$86.78M derived: sum of 2 quarters · filed 2020-11-10 | -$97.65M 10-Q · filed 2020-11-10 | -$133.50M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | -$46.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$57.56M 10-Q · filed 2020-08-12 | -$93.41M derived: sum of 3 quarters · filed 2021-03-01 | -$136.96M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | -$10.87M 10-Q · filed 2020-05-13 | -$46.72M derived: sum of 2 quarters · filed 2021-03-01 | -$90.26M derived: sum of 3 quarters · filed 2021-03-01 | -$97.02M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | -$35.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$79.39M derived: sum of 2 quarters · filed 2021-03-01 | -$86.14M derived: sum of 3 quarters · filed 2021-03-01 | -$105.05M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$43.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$50.30M derived: sum of 2 quarters · filed 2020-11-10 | -$69.20M 10-Q · filed 2020-11-10 | -$83.14M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$6.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$25.66M 10-Q · filed 2020-08-12 | -$39.59M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$18.90M 10-Q · filed 2020-05-13 | -$32.84M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$13.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$29.53M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$15.60M 10-Q · filed 2019-11-14 |